Safety and Efficacy of Stem Cell Transplantation for Treatment of Liver Cirrhosis
This study is currently recruiting participants.
Verified October 2012 by General Hospital of Chinese Armed Police Forces
Sponsor:
General Hospital of Chinese Armed Police Forces
Collaborators:
Xinjiang Armed Police Corps Hospital
Taian Hospital of Traditional Chinese Medicine
Information provided by (Responsible Party):
General Hospital of Chinese Armed Police Forces
ClinicalTrials.gov Identifier:
NCT01491165
First received: December 8, 2011
Last updated: October 25, 2012
Last verified: October 2012
History of Changes
Purpose
Mainstream of current treatment of liver cirrhosis is liver transplantation, but there are high cost, risk and immune rejection and other issues. Umbilical cord mesenchyma stem cell with self-and directed differentiation capacity can effectively rescue experimental liver failure and contribute to liver regeneration, which suggests the feasibility of stem cell transplantation therapy. In this study, the safety and efficacy of umbilical cord mesenchyma stem cell transplantation through interventional procedures in patients liver cirrhosis will be evaluated.
Locations
China
Yihua An Recruiting
Beijing, China
Contact: Yihua An, doctor 0086-10-88276848 [email protected]